Historical record - last NADAC publication: 2/21/2024
Product Information
FENOFIBRATE 67 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.1138 per EA under NDC 69097089407. Its NADAC has been published 354 times since May 17, 2017.
Strength
67 mg/1
Manufacturer
Cipla USA Inc.NDC
69097089407
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/21/2024
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207378On Market Since
3/30/2017
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 67 MG CAPSULE has been published 354 times since May 17, 2017, and over the history we have for it it has declined 81.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1138 per EA |
|---|---|
| All-time high | $0.6545 (Jul 12, 2017) |
| All-time low | $0.0801 (Apr 19, 2023) |
| Median price | $0.3078 |
| Average price | $0.2813 |
| Largest weekly change | +67.0% (Mar 23, 2022) |
| Weeks tracked | 354 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 67 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 67 MG CAPSULE, manufactured by Cipla USA Inc., is $0.1138 per EA (NDC 69097089407), effective Feb 21, 2024.
How has the price of FENOFIBRATE 67 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 67 MG CAPSULE has declined 81.7%. It has been tracked across 354 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 67 MG CAPSULE?
Since May 17, 2017, the NADAC for FENOFIBRATE 67 MG CAPSULE has ranged from a low of $0.0801 (Apr 19, 2023) to a high of $0.6545 (Jul 12, 2017), with a median of $0.3078 per EA.
Are there cheaper alternatives to FENOFIBRATE 67 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, FENOFIBRATE 67 MG CAPSULE, is $0.0885 per EA — about 22% below FENOFIBRATE 67 MG CAPSULE.
Who manufactures FENOFIBRATE 67 MG CAPSULE?
FENOFIBRATE 67 MG CAPSULE (NDC 69097089407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification